Qianhai Health Holdings Limited (QIANHAI HEALTH) has filed its Monthly Return for Equity Issuer covering the period to 30 June 2026, confirming stable share capital metrics and adherence to Hong Kong Stock Exchange (HKEX) public-float requirements.

The authorised share capital stood unchanged at 500.00 million ordinary shares with a par value of HKD 0.40 each, representing total authorised capital of HKD 200.00 million.

Issued share capital also remained constant. The company closed June with 169.45 million issued shares, identical to the May balance. No treasury shares were held, issued, cancelled or transferred during the month, and there were no new share issues, repurchases, or redemptions.

QIANHAI HEALTH confirmed compliance with the HKEX initial prescribed public-float threshold of 25%, indicating that at least one-quarter of its issued shares remained in public hands as at 30 June 2026.

No movements were recorded under share option schemes, warrants, convertible instruments, or other equity-linked agreements.

The monthly return, submitted on 3 July 2026 by Company Secretary Yip Tak Yung Teresa, affirms that all regulatory and corporate governance obligations related to the company’s share capital were satisfied during the reporting period.